000			04948nam a22003855i 4500
001			394886
003			ES-MaUEC
005			20230102123206.0
007			cr nn 008mamaa
008			220808s2022 si | s |||| 0|eng d
020			_a9789811918544
024	7		_a10.1007/978-981-19-1854-4 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
245	1	0	_aAlternatives to Antibiotics _bRecent Trends and Future Prospects _cedited by Tilak Saha, Manab Deb Adhikari, Bipransh Kumar Tiwary
250			_a1st edition 2022
264		1	_aSingapore _bSpringer International Publishing _c2022
300			_a1 recurso en línea (XXIII, 571 páginas) _b70 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
505	0		_aChapter 1. Quest for alternatives to antibiotics - an urgent need of the 21st century -- Chapter 2. Phytochemicals as antibacterial agents: current status and future perspective -- Chapter 3. Quorum quenching enzymes: a potent alternative to conventional antibiotics -- Chapter 4. Antibodies as antibacterial molecules: the new era of antibody-mediated immunity -- Chapter 5. Phage therapy: genomics to applications and future prospects -- Chapter 6. Alternatives to antibiotics in animal farming -- Chapter 7. Metal catalysed synthesis of b-lactam antibiotics -- Chapter 8. Upgrading the antibiotic arsenal against gram-positive bacteria: chemical modifications of vancomycin -- Chapter 9. Heterocyclic scaffolds in novel synthetic antibacterial agents -- Chapter 10. Antibacterial metal-organic frameworks -- Chapter 11. Cationic amphiphilic molecules as bactericidal agents -- Chapter 12. Polymeric nanoparticles and nanocomposites as antibacterial agents -- Chapter 13. Metallic nanoparticles and their composites as alternative antibacterial therapeutics -- Chapter 14. Carbon nanoparticles as the next generation antimicrobial agents -- Chapter 15. Dendrimeric entities as chemical alternatives towards antimicrobial therapy -- Chapter 16. Ionic liquids, ionic liquid nanoparticles and nanocomposites-the future antibiotics -- Chapter 17. Prebiotic immunomodulators to enhance mucosal immunity and to reduce mass use of antibiotics -- Chapter 18. Use of probiotics, prebiotics and synbiotics as an alternative to antibiotics -- Chapter 19. The implication of antimicrobial peptides against bacteria and their clinical aspects -- Chapter 20. development of probiotics for helocibacter pylori infection management -- Chapter 21. Implications of probiotics in management of bacterial infections -- Chapter 22. Nano carriers for the molecular targeting of pathogenic bacteria.
520			_aThis book discusses prospective alternative approaches to fight bacterial infections to minimize the indiscriminate use of conventional antibiotics. It offers the current knowledge on research and development of alternative antibacterial agents such as probiotics, nanobiotics etc. while it also discusses newly emerging trends such as phage therapy, antibody therapy etc. The book highlights on the phytochemicals with potent antibacterial activities as alternatives to conventional antibiotics. Chemical modification to develop next generation antibiotics with enhanced efficacy has also been included. Such modifications are reported to overcome the inherent resistance of the parent antibiotics. Phage therapy and targeted antibodies are considered as potential alternative approaches to treat bacterial ailments and represent areas of cutting-edge research and have therefore been discussed with sufficient care. Mainly, the book highlights various approaches other than conventional antibiotics in treating bacterial infections. The scientific advancements in these areas will strengthen the 'One Health' approach benefiting human beings, animals and environment as well. This book is a comprehensive resource to cater researchers, biological scientists, herbalists and clinical practitioners with up-to-date information on antibacterials other than antibiotics.
700	1		_aSaha, Tilak _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aDeb Adhikari, Manab _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aTiwary, Bipransh Kumar _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9789811918537
776	0	8	_iPrinted edition: _z9789811918551
776	0	8	_iPrinted edition: _z9789811918568
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-19-1854-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
988			_aSpringer_BiomedLife_2022
999			_c394886 _d394886